ITPC MENA ITPC MENA
Apr 25, 2023

New Study: The Impact of the COVID-19 Health Crisis on Access to HIV Services in Egyp

Advocacy, AIDS, ARV, Egypt, Guidelines, HCV, Health Financing, HIV, Middle East, Morocco, North Africa, Pathology, Tunisia 30 Views

A study was carried out by the FORSS consortium which includes (ITPC-MENA, Solidarité SIDA, AGD, ATP+, Al Shehab RdR Maroc, and M-Coalition). This recently developed report analyzes the impact of the COVID-19 pandemicRead More

Sep 14, 2018

The MENA Community Advisory Board (MENA-CAB) 2017 Report

Advocacy, AIDS, ARV, Hepatitis, HIV, Intellectual Proprety, North Africa, TB 11 Views

The Community Advisory Board (CAB) constitutes a space of exchange between advocates from the MENA region,  researchers and drug manufacturers, with the aim to educate people living with HIV and their advocates onRead More

Feb 16, 2018

Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!

Advocacy, AIDS, ARV, Guidelines, HIV 10 Views

Source : The Global Network of People living with HIV GNP+ What do people living with HIV need to know about Dolutegravir? What do our communities need to know about viral resistance toRead More

Jul 26, 2017

IAS 2017: Closing ceremony exposes Gilead Sciences

Advocacy, ARV, HCV, Hepatitis, Intellectual Proprety, Medias 11 Views

Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), drew to a close, in style. The community addressRead More

Jul 25, 2017

A new victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on A

Advocacy, AIDS, Algeria, ARV, Guidelines, HIV, Intellectual Proprety, Medias, Middle East, Morocco, North Africa, Tunisia 13 Views

The 9th International AIDS Society Conference on HIV / AIDS 2017 : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt, a victory for ITPC-MENA Today, at the World Conference on AIDS,Read More

Jul 25, 2017

BLOG: We want dolutegravir for all, and we want it now

Advocacy, AIDS, ARV, Dolutegravir, Guidelines, HIV, Middle East, North Africa 15 Views

Source: makemedicinesaffordable Author: Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC). Article first published on the Huffington Post here. We’re calling for a compulsory licenseRead More

Jul 24, 2017

HIV Activists Denounce ViiV for Denying 3.5 million People Access to Optimal Treatmen

Advocacy, AIDS, ARV, HCV, Health Financing, Hepatitis, HIV, Intellectual Proprety, Non classé 12 Views

Source : ITPC GLOBAL Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment activists from around the world collectively blocked access toRead More

Jul 21, 2017

ITPC MENA IN THE REGIONAL CONSULTATION ON ACCELERATING ACCESS TO THE CONTIUUM OF HIV

Advocacy, AIDS, ARV, Daclatasvir, Dolutegravir, Guidelines, HIV, Middle East, Morocco, North Africa 12 Views

Beirut, Lebanon, 12–14 July 2017 By the end of 2015, the estimated number of people living with HIV in the Region had reached 330 000. With a continuously growing epidemic coupled with lowRead More

Jul 20, 2017

New WHO Guidance Report- Treatment Failure and Drug Resistance

Advocacy, AIDS, ARV, Daclatasvir, Dolutegravir, Guidelines, HIV, Pathology, The Global Fund 11 Views

WHO urges action against HIV drug resistance threat 20 JULY 2017 | GENEVA – WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveysRead More

Jun 1, 2017

US Supreme Court Adopts International Exhaustion For Patents: Paving the way for para

Advocacy, AIDS, ARV, Hepatitis, HIV, Medias, News, TB 15 Views

Source : By Frederick M The Supreme Court of the United States on May 30, 2017 adopted a rule of international exhaustion of patent rights for the United States in Impression Products v.Read More

1 2

Récents Articles

Call for Applications: Scholar 05 Sep 23 34 Views
New Study: The Impact of the C 25 Apr 23 30 Views
MENACAB 2021 – 2022 REPO 13 Mar 23 17 Views
CALL FOR APPLICATION: ACTIVIST 08 Aug 22 19 Views
Call for applications: Partici 31 Mar 22 16 Views

Archives

  • September 2023
  • April 2023
  • March 2023
  • August 2022
  • March 2022
  • February 2022
  • December 2021
  • October 2021
  • September 2021
  • June 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • February 2020
  • May 2019
  • December 2018
  • October 2018
  • September 2018
  • June 2018
  • May 2018
  • April 2018
  • February 2018
  • January 2018
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • January 2017
  • December 2016
  • May 2016
  • April 2016
  • February 2016
  • January 2016
  • November 2015
  • October 2015
  • June 2015
  • May 2015
  • July 2014
  • February 2014
  • November 2013
  • September 2013
  • July 2013
  • July 2012

RESTONS CONNECTÉS :

Rejoignez-nous sur les réseaux sociaux pour rester informé.

58 Bd Abdelkrim Al Khattabi, Marrakech 40000

05244-23355

admin@itpcglobal.com

  • Facebook
  • Instagram
  • Twitter

LIENS UTILES :

  • À Propos
  • Notre travail
  • Ressources
  • Actualités
  • Appels d’Offres

Copyright © ITPC MENA | All rights reserved.